Nuveen’s Advent Technologies ADN Stock Holding History

Nuveen’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,345	Closed	-$120K	–	3230
2022 Q1	$120K	Hold	1,345	–	–	﹤0.01%	3239
2021 Q4	$315K	Hold	1,345	–	–	﹤0.01%	3168
2021 Q3	$358K	Buy	1,345 +437	+48%	+$106K	﹤0.01%	3225
2021 Q2	$263K	Buy	+908	New	+$302K	﹤0.01%	3228

Other funds holding ADN

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PSCM

Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen's ADN Position: Q2 2022 in Review

Nuveen sold out of Advent Technologies (ADN) in Q2 2022, closing a stake of 1,345 shares — an estimated $120K sold.

Nuveen first reported a position in ADN in Q2 2021 and held it in 4 quarters. The position peaked at $358K in Q3 2021. 49 funds tracked by Wall St. Rank hold ADN as of Q2 2022.

Nuveen reported no remaining Advent Technologies position as of Q2 2022 after selling out during the quarter.
Nuveen sold 1,345 Advent Technologies shares in Q2 2022, an estimated $120K.
Nuveen first reported a position in Advent Technologies in Q2 2021 and held it in 4 quarters.
Nuveen's Advent Technologies position peaked at $358K in Q3 2021.
49 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.